SUBSCRIBE
SUBSCRIBE

Marketing

IN PARTNERSHIP WITH INTELLIA THERAPEUTICS
The commercial launch playbook: Team structure, readiness and execution
Intellia Therapeutics’s Senior Vice President Maria Natale discusses why the most successful launches are shaped long before approval, with strategy, structure and patient insight at the core.
June 15, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
PRESS RELEASES
Press Releases
Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
October 30, 2026
 · 
7 min read
Press Releases
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
October 29, 2026
 · 
8 min read
Press Releases
LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
October 29, 2026
 · 
16 min read
Press Releases
Bio-Thera Announces NMPA Approval of BAT2306, the First Secukinumab Biosimilar Approved in China
October 26, 2026
 · 
4 min read
Press Releases
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
October 23, 2026
 · 
3 min read
Press Releases
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
October 22, 2026
 · 
8 min read
Press Releases
Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy
October 22, 2026
 · 
7 min read
Press Releases
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
October 21, 2026
 · 
6 min read
Press Releases
Hologic and Inpeco Announce Co-Marketing Partnership to Advance Molecular Laboratory Automation
October 20, 2026
 · 
4 min read
Press Releases
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
October 19, 2026
 · 
4 min read
Press Releases
Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
October 16, 2026
 · 
7 min read
Press Releases
Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA
October 16, 2026
 · 
9 min read
Press Releases
Revolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
October 15, 2026
 · 
13 min read
Press Releases
JCR Pharmaceuticals Receives Marketing Authorization in Kuwait for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
October 15, 2026
 · 
10 min read
Press Releases
Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1
October 15, 2026
 · 
6 min read
Press Releases
Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
October 8, 2026
 · 
8 min read
Press Releases
Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer
October 8, 2026
 · 
8 min read
Press Releases
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms
October 5, 2026
 · 
8 min read
Press Releases
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
October 2, 2026
 · 
5 min read
Press Releases
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
October 1, 2026
 · 
6 min read